Edwards Lifesciences Corporatio vs Johnson & Johnson — Stock Comparison
Edwards Lifesciences Corporatio (EW) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Edwards Lifesciences Corporatio narrowly edges Johnson & Johnson on Q·Score (7 vs 6.6 out of 10), led by Health (9.2 vs 6.5) and Growth (5.2 vs 4.3). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for EW (+10.7%) than for JNJ (+2.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.1× debt-to-equity).
⚠ earnings contracting 25% year-over-year.
High-quality business with 20% return on equity and 16% profit margins.
⚠ earnings contracting 96% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
EW vs JNJ: which stock scores better overall?
Based on Q·Score, Edwards Lifesciences Corporatio (EW) scores 7/10 versus Johnson & Johnson (JNJ) at 6.6/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: EW or JNJ?
Edwards Lifesciences Corporatio (EW) scores higher on Growth (5.2/10 vs 4.3/10). Edwards Lifesciences Corporatio reports revenue growth (13.6% YoY) while Johnson & Johnson reports (5.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is EW or JNJ more attractively valued?
Edwards Lifesciences Corporatio (EW) scores higher on Valuation (6.3/10 vs 5.8/10). EW trades at 27.2× P/E versus JNJ at 23.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about EW vs JNJ?
There are 27 analysts covering EW with a consensus price target of $101.87, and 22 analysts covering JNJ with a consensus target of $279.41. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: EW or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (8.5/10 vs 6.7/10). Net profit margin: EW at 15.4%, JNJ at 16.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: EW or JNJ?
Edwards Lifesciences Corporatio (EW) scores higher on Financial Health (9.2/10 vs 6.5/10). Market beta: EW at 0.86, JNJ at 0.21. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of EW and JNJ?
Edwards Lifesciences Corporatio (EW) has a market capitalisation of $53.0B, while Johnson & Johnson (JNJ) has a market cap of $657.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do EW or JNJ pay dividends?
EW does not currently pay a dividend, while JNJ pays a dividend yield of 1.95%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →